• Accueil >
  • Publications >
  • SF3B1 mutations constitute a novel therapeutic target in breast cancer

SF3B1 mutations constitute a novel therapeutic target in breast cancer

1 mars 2015The Journal of Pathology

DOI : 10.1002/path.4483

Auteurs

Sarah L Maguire, Andri Leonidou, Patty Wai, Caterina Marchiò, Charlotte KY Ng, Anna Sapino, Anne‐Vincent Salomon, Jorge S Reis‐Filho, Britta Weigelt, Rachael C Natrajan